StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.85+0.04 (+5.13%)

Close on Nov 18, 2026Market cap $109.79MP/E –Yield –

Organogenesis market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Organogenesis's market cap was $135.11M on Nov 11, 2026, against $657.40M a year earlier. Over the last 5 years it ranged from $98.83M to $1.19B, with a median of $424.24M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$135.11M-79.4%
2025Dec 31, 2025$657.40M+55.0%
2024Dec 31, 2024$424.24M-21.0%
2023Dec 29, 2023$537.07M+52.5%
2022Dec 30, 2022$352.16M-70.4%
2021Dec 31, 2021$1.19B+46.9%
2020Dec 31, 2020$809.15M+77.6%
2019Dec 31, 2019$455.71M-32.1%
2018Dec 31, 2018$670.66M+32.6%
2017Dec 29, 2017$505.72M–

More Organogenesis figures

See a number that looks wrong?